Stephan Busque

Publication Details

  • 12-MONTH RESULTS OF TOFACITINIB (CP-690,550)-BASED CNI-FREE IMMUNOSUPPRESSION IN A PHASE 2B STUDY IN DE NOVO KIDNEY TRANSPLANT PATIENTS Vincenti, F., Silva, H. T., Busque, S., O'Connell, P., Friedewald, J., Cibrik, D., Budde, K., Yoshida, A., Cohney, S., Weimar, W., Kim, Y. S., Lawendy, N., Lan, S., Kudlacz, E., Krishnaswami, S., Chan, G. WILEY-BLACKWELL. 2011: 97-97

    View details for Web of Science ID 000294869600332

Stanford Medicine Resources:

Footer Links: